Common Paediatric Viruses
Measles
·
Highly contagious paramyxovirus
spread by coughing and nasal droplets
·
Epidemiology:
o Overall mortality 0.5%
o Risk of infection 100% if not immunised
o Epidemics occur every 7 years
o Incidence up to 3000 notifications in epidemic years. Lab confirmations drop in epidemics as high incidence ® high PPV of clinical diagnosis. Very few cases in non-epidemic years will actually be measles
·
Presentation:
o Incubation 10 – 14 days
o Fever, ALWAYS a cough (“measles bronchiolitis), coryza, conjunctivitis for 2 –3 days
o Then red maculo-papular rash beginning on face and spreading to rest of body. White spots on cheery-red buccal mucosa for 24 hours before rash (Koplik‟s Spots) – pathognomonic
·
Treatment: Supportive,
antibiotics for 2ndary infection
·
Complications:
o Otitis media (10%)
o Pneumonia (1 – 5%)
o Encephalitis (0.1%): 15% die and 25% left severely disabled. 1 in
100,000 develop the fatal grey matter degenerative disorder Subacute Sclerosing
Panencephalitis (SSPE)
· Vaccine:
o Live attenuated virus. Now MMR2 given at 4 years to time between epidemics and address 2 – 5% chance of primary vaccine failure in first dose
o Mild fever, malaise or rash develops in about 1% 7 – 10 days after
vaccination
o 1 in 1 million develop encephalitis (1,000 fold less likely than if
infected with wild virus)
o Contraindicated during pregnancy and in immunocompromised hosts
·
Contagious paramyxovirus spread
by saliva and droplets
·
~ 80 notified cases per
annum. Used to be 3 – 4 year epidemics,
now longer
·
Presentation:
o Incubation 2 – 3 weeks
o 70% develop fever and swelling and tenderness of salivary glands
o 15% have aseptic meningitis
o 0.2% develop encephalitis
o 20% of post-pubertal males have painful orchitis
o Case fatality is 0.02% - usually from encephalitis
· Infective 1 week before and after parotid swelling starts
·
Vaccine: Live attenuated virus
(contraindicated during pregnancy and immunosuppression). Efficacy 95%. Only
introduced because it can piggy back other vaccinations
· Include Coxsackie A and B, echoviruses and enteroviruses
· Cause: non-specific febrile
illnesses, pharyngitis, gastroenteritis, viral meningitis, encephalitis,
pericarditis, myocarditis, hepatitis, haemorrhagic conjunctivitis, etc
· Viral exanthem: macular rashes, maculo-papular, vesicular and petechial rashes
· Hand, Foot and Mouth Disease: Coxsackie A16. Mild illness, low-grade fever and sore throat. Scattered vesicular lesions in the mouth with similar lesions surrounded by erythematous areolae on the hands and feet.
· Incubation for 3 – 6 days, infectious for at least 1 week after onset of symptoms
·
Diagnosis: culture (including
from faeces – if isolates persist for several weeks may be unrelated to
illness), possible PCR for blood and CSF. Serology difficult
· Acute febrile illness of young children for several days with occipital adenopathy, then reduced fever and appearance of a fine red maculo-papular rash over the trunk and arms for 1 – 2 days (confused with antibiotic rash)
·
70% of 2 year olds are
sero-positive. Serology and PCR
problematic due to latent infection
·
Incubation 5 – 15 days
·
Rare complications: encephalitis
or benign intracranial hypertension
·
= Erythema Infectiosum or Slapped
Cheek Syndrome
· Mild illness, fever in 30%, bright red rash on cheeks for 2 – 3 days
· A few days later, a maculo-papular, then lace-like rash may appear on arms, then trunk, buttocks and thighs. May recur over following weeks after hot baths
·
Incubation 4 – 14 days
· Infectious period is before the rash appears
· Complications: Adolescents and
adults may also have polyarthralgia/arthritis, aplastic crisis if chronically
anaemic (eg immunocompromised)
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.